Vaginal mesh study reveals how lax medical regulation puts women at risk

Failures in the regulation of vaginal mesh implants put women at risk of serious infection and chronic pain, experts have said.

Researchers found that lax rules on medical devices, which allow products to be approved on an “equivalence” basis if they’re similar to an already approved device, allowed 61 mesh implants to be marketed based on evidence for two older products.

While regulators have plans in place to tighten up oversight, including requiring clinical trials for each medical device in line with drug approval, these will not be fully in place until 2020.

The academics from Oxford University argue that a public registry

To see the full content, share this page by clicking one of the buttons below

Click here to Read from the source

x

Check Also

Brexit: Second referendum would be 'extremely unhelpful' says Labour frontbencher

A Labour shadow Cabinet minister has said a another EU referendum would be “extremely unhelpful” ...

Shares